IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Avidity Partners Management LP

Q4 2024 Holdings

Filed 2025-02-14 | 63 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Acadia Healthcare Company in(ACHC)COM00404A109$26.1M658,0002.6%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$27.5M666,2002.7%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$28.9M234,5002.8%
Ideaya Biosciences Inc(IDYA)COM45166A102$29.0M1,126,7002.8%
Neurocrine Biosciences Inc(NBIX)COM64125C109$30.1M220,4003.0%
Unitedhealth Group Inc(UNH)COM91324P102$30.4M60,0003.0%
CG Oncology Inc(CGON)COM156944100$31.5M1,097,8003.1%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$33.8M64,8003.3%
Exact Sciences Corp(EXAS)COM30063P105$33.9M603,0113.3%
Natera Inc(NTRA)COM632307104$35.4M223,8003.5%
Janux Therapeutics Inc(JANX)COM47103J105$39.7M741,9003.9%
Boston Scientific Corp(BSX)COM101137107$46.0M515,0004.5%
Dianthus Therapeutics Inc(DNTH)COM252828108$62.6M2,873,0006.2%
PreviousPage 2 of 2